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Summary
Small low-density lipoprotein (LDL) particles are a ge-
netically influenced coronary disease risk factor. Lipo-
protein lipase (LpL) is a rate-limiting enzyme in the for-
mation of LDL particles. The current study examined
genetic linkage of LDL particle size to the LpL gene in
five families with structural mutations in the LpL gene.
LDL particle size was smaller among the heterozygous
subjects, compared with controls. Among heterozygous
subjects, 44%were classified as affected by LDL subclass
phenotype B, compared with 8% of normal familymem-
bers. Plasma triglyceride levels were significantly higher,
and high-density lipoprotein cholesterol (HDL-C) levels
were lower, in heterozygous subjects, compared with
normal subjects, after age and sex adjustment. A highly
significant LOD score of 6.24 at was obtained forv  0
linkage of LDL particle size to the LpL gene, after ad-
justment of LDL particle size for within-genotype var-
iance resulting from triglyceride and HDL-C. Failure to
adjust for this variance led to only a modest positive
LOD score of 1.54 at . Classifying small LDL par-v  0
ticles as a qualitative trait (LDL subclass phenotype B)
provided only suggestive evidence for linkage to the LpL
gene ( at ). Thus, use of the quanti-LOD  1.65 v  0
tative trait adjusted for within-genotype variance, re-
sulting from physiologic covariates, was crucial for de-
tection of significant evidence of linkage in this study.
These results indicate that heterozygous LpL deficiency
may be one cause of small LDL particles and may pro-
vide a potential mechanism for the increase in coronary
disease seen in heterozygous LpL deficiency. This study
also demonstrates a successful strategy of genotypic spe-
cific adjustment of complex traits in mapping a quan-
titative trait locus.
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Introduction
A growing body of evidence supports the role of small,
dense low-density lipoprotein (LDL) particles as a risk
factor for coronary disease. Case-control studies have
demonstrated consistently that a predominance of small,
dense LDL particles is more common in individuals with
coronary disease than in control subjects (Fisher 1983;
Crouse et al. 1985; Austin et al. 1988a; Griffin et al.
1990; Tornvall et al. 1991; Campos et al. 1992; Coresh
et al. 1993; Jaakkola et al. 1993; Griffin et al. 1994),
and recent prospective studies indicate that the presence
of small, dense LDL particles predict subsequent coro-
nary disease events (Gardner et al. 1996; Stampfer et al.
1996; Lamarche et al. 1997). The association between
small, dense LDL particles and coronary disease, how-
ever, may not be independent of other lipid factors. In
particular, adjustment for plasma triglyceride (Tg) and
high-density lipoprotein cholesterol (HDL-C) attenuates
the magnitude of the association between small, dense
LDL particles and coronary disease. A number of studies
have shown a clustering of small, dense LDL particles,
elevated Tg, and low HDL-C within individuals, leading
to the proposal for an atherogenic lipoprotein phenotype
(Austin et al. 1990b), a constellation of abnormalities
that may indicate a common underlying cause leading
to increased coronary-disease risk.
Studies have demonstrated both genetic and environ-
mental influences on small, dense LDL particles. Com-
plex segregation analysis in healthy families (Austin et
al. 1988b; de Graaf et al. 1992; Austin et al. 1993a) and
in families with familial combined hyperlipidemia
(FCHL; Austin et al. 1990a; Bredie et al. 1996) provide
evidence of a single major gene influencing small, dense
LDL particles. In addition, these studies indicate that the
expression of this complex trait is influenced by age, sex,
menopausal status, and oral contraceptive use. Twin
studies also indicate the presence of genetic and envi-
ronmental influences on LDL particle distribution, with
a range of 0.39–0.55 for heritability estimates (Lamon-
Fava et al. 1991; Austin et al. 1993b). Genetic hetero-
geneity controlling LDL particle size is suggested by re-
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ports that several loci may be linked genetically to LDL
particle size. Nishina et al. (1992) reported linkage of
small, dense LDL particles to markers for the LDL re-
ceptor (LDL-R) gene; however, no structural variants in
the LDL-R gene were found in these families (Naggert
et al. 1997). One sib-pair analysis has suggestedmultiple
loci controlling LDL particle size (Rotter et al. 1996),
including the LDL-R gene and the superoxide dismutase
gene. Although linkage was suggestive for markers at
the apo-C-III gene and the cholesterol ester transfer pro-
tein gene (Rotter et al. 1996), these values did not reach
conventional thresholds for statistical support of genetic
linkage (Morton 1955). A recent sib-pair analysis in fe-
male twins suggested linkage of LDL particle size to the
apo-B gene but did not provide significant evidence for
linkage of LDL particle size to the LDL-R gene or to the
apo-C-III gene (Austin et al. 1998). At present, there is
no definitive confirmation of the role of these genes in
controlling LDL particle size.
Lipoprotein lipase (LpL) is an essential enzyme in the
formation of LDL particles (Zambon et al. 1993). LpL
hydrolyzes core Tg from very-low-density lipoproteins
(Magill et al. 1982), a saturable process that leads to
the formation of remnant lipoproteins, which then may
be degraded by the liver or converted to LDL particles
(Brunzell et al. 1973). Low levels of LpL activity are
associated with an increase in LDL particle density
(Hokanson et al. 1997b). More than 60 structural mu-
tations in the LpL gene on chromosome 8p22, which
abolish LpL activity and lead to LpL deficiency, have
been identified (Brunzell 1995). Heterozygosity for these
mutations is associated with low levels of LpL activity,
elevated Tg, and low levels of high-density lipoprotein
(HDL; Babirak et al. 1989; Emi et al. 1990; Wilson et
al. 1990; Miesenbock et al. 1993). Preliminary data also
indicate that LpL heterozygosity is associated with LDL
particle density (Zambon et al. 1996) and small LDL
particles, in one family (Miesenbock et al. 1993). In
addition, there are structural mutations in the LpL gene
that are associated with coronary disease (Hokanson
1997; Nordestgaard et al. 1997). These observations
lead to the hypothesis that mutations in the LpL gene
may be one cause of the small, dense LDL particle
phenotype.
The purpose of the present study was to determine
whether the LpL gene is a quantitative trait locus (QTL)
responsible for LDL particle size variation in families
with known structural mutations in the LpL gene. The
approach used to determine this was the classic LOD
score–linkage method. This report also compared the
ability of the LOD score method to detect linkage for a
qualitative trait (LDL subclass phenotype) versus a
quantitative trait (LDL particle size), and evaluated the
impact on linkage analysis of appropriate within-ge-
notype adjustment for physiologic covariates.
Families and Methods
Family Selection
Families were identified through probands, referred
for LpL deficiency, with a structural mutation in the LpL
gene. Families were ascertained in this way because (1)
the genetic markers used to genotype family members
are functional mutations, not merely noncoding poly-
morphic markers; (2) the sample was as homogeneous
as possible, with respect to LpL lipolytic function,
thereby minimizing the necessary sample size; and (3)
the information for linkage analysis to the LpL gene was
maximized through sequential sampling on the basis of
heterozygous genotypes.
Five extended kindreds were identified through pro-
bands referred for LpL deficiency, in which a primary
defect in the LpL gene causing defective LpL lipolytic
activity was identified (fig. 1). Four probands were re-
ferred as infants with chylomicronemia and failure to
thrive (families 1, 2, 4, and 5), and the proband from
family 3 was identified as a young man with severe hy-
pertriglyceridemia. The presence of coronary disease in
these families was not a criterion for selection. Probands,
children !6 years of age, and pregnant women were
excluded from the analysis. To maximize information
for the linkage analysis, family members were recruited
for this study on the basis of sequential sampling of first-
degree relatives of individuals with an LpL mutation
(Cannings and Thompson 1977). Of the 171 eligible
subjects identified within these 5 families, 151 were con-
tacted to participate in this study. We were unable to
contact 20 potential subjects. Of the 151 potential par-
ticipants, 21 did not meet the eligibility criteria and 10
refused to participate, resulting in a sample of 120 sub-
jects for the analysis. The study design was approved by
the University of Washington Human Subjects Com-
mittee, and all subjects provided written informed
consent.
Laboratory Methods
Blood was collected in tubes containing 0.1% EDTA,
from individuals who had fasted for 12 h. Each sample
was centrifuged immediately, and plasma and white cells
were kept at 4C. Plasma was assayed for lipids and
apo-B or was frozen at 70C within 24 h of the blood
draw. LDL particle size determination was performed
on plasma frozen at 70C within 24 h of the blood
draw. Cells were stored at 4C, prior to DNA extraction.
LDL particle size was determined by use of nonden-
aturing gradient-gel electrophoresis (Krauss and Burke
1982) with polyacrylamide gradients gels produced in
our laboratory (Hokanson et al. 1997a). Whole plasma
or LDL, isolated by sequential ultracentrifugation (Ha-
vel et al. 1955) and standards of known diameter, were
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Figure 1 Pedigrees of families with mutations in the LpL gene. Panel A, family 1. Panel B, family 2. Panel C, family 3. Panel D, family
4. Panel E, family 5. Arrows identify probands. Blackened symbols indicate LpL-deficient subjects. Note that all probands and LpL-deficient
subjects were excluded from this analysis (see Families and Methods). Dark-bordered symbols indicate subjects heterozygous for mutations in
the LpL gene. Light-bordered symbols indicate subjects homozygous for normal LpL alleles. Hatched-bordered symbols indicate subjects not
sampled. Ages are indicated within the symbols. LDL subclass phenotype and LDL particle size (A˚) are indicated below the symbol.
electrophoresed for 24 h at 125V (3,000 V-h), stained,
and subjected to densitometry, and the diameter of the
major peak of LDLwas determined by use of a quadratic
calibration curve of migration distance and particle di-
ameters of the standards. LDL particle–size measure-
ment is highly reproducible, with a coefficient of vari-
ation of 1.5% from 122 consecutive gels (Austin et al.
1995). LDL subclass phenotypes were defined as de-
scribed elsewhere (Austin et al. 1988a; Austin et al.
1990b).
Cholesterol and Tg levels were measured by means of
enzymatic methods, HDLwas separated with use of dex-
tran sulfate, and LDL cholesterol was calculated on the
basis of the Friedewald equation (Capell et al. 1996). If
Tg was 1400 mg/dl, LDL cholesterol was calculated as
the difference between the cholesterol in the d ! 1.006
gm/ml fraction (Havel et al. 1955), minus the cholesterol
in the dextran sulfate supernatant. The amount of apo-
B was measured in plasma by immunonephelometry
(Behring Diagnostic) with a polyclonal antibody (Mar-
covina et al. 1991). These measurements were performed
at the Northwest Lipid Research Laboratory.
We extracted genomic DNA from leukocytes, after
erythrocyte lysis, using 13.1 mM ammonium chloride
and 0.9 mM ammonium bicarbonate (Poncz et al. 1982),
by salt deproteinization (Miller et al. 1988), and resus-
pended it in 10 mM Tris-HCl, 0.2 mM Na2EDTA (pH
7.5). The presence of variant LpL alleles was determined
by means of primers and restriction enzymes, noted in
table 1. Each gel contained a positive and negative con-
trol DNA. An LDL-R mutation (W66G) in family 2 was
identified by use of dot-blot oligonucleotide hybridiza-
tion (Leitersdorf et al. 1990).
Statistical Analysis
Analysis of differences in lipids and lipoproteins be-
tween heterozygous and normal family members used a
robust estimator of variance to account for the lack of
strictly independent observations resulting from genetic
relationships, with the degrees of freedom determined
on the basis of the number of families (i.e., five) (Lee et
al. 1991; STATA statistical software). Regression anal-
ysis also used the reduced degrees of freedom, on the
basis of clustered observations. All quantitative variables
were adjusted linearly for age and sex, prior to analyses.
There was no difference in the distribution of age or sex
between LpL heterozygous and homozygous normal
subjects (table 2); therefore, these adjustments were per-
formed in the whole study population, irrespective of
LpL genotype. Age and sex accounted for 9% of the
variance in LDL particle size in this sample. Tg was
transformed by the natural logarithm (ln).
Linkage analysis was performed by use of LOD score
methods. We analyzed linkage of LDL subclass pheno-
type B (narrow definition; Austin et al. 1988b) to the
LpL gene using model parameters, estimated from a
prior segregation analysis, inMormon families primarily
(Austin et al. 1988b). There generally is less tobacco use
and alcohol consumption among Mormons, and there-
fore there may be less confounding as a result of these
factors in the segregation analysis. However, the segre-
gation of LDL subclass phenotype B was similar in the
one large non-Mormon kindred compared with the
Mormon kindreds (Austin et al. 1988b). Although this
segregation analysis could not exclude any specific sin-
gle-gene mode of inheritance, the current linkage anal-
ysis used the model with a dominant mode of inheri-
tance, done on the basis of maximum-likelihood
estimation (i.e., a smaller 2 ln likelihood). The allele
frequency was .25. Penetrance classes were determined
on the basis of age, sex, and menopausal status. Spe-
cifically, the penetrance of phenotype B was estimated
to be 17% for males 20 years of age, 82% for males
120 years of age, 21% for premenopausal women, and
95% for postmenopausal women (Austin et al. 1990a).
Because medications that alter Tg levels may influence
LDL subclass phenotypes (Austin et al. 1994), subjects
taking fibric-acid derivatives ( ) were classified inton  7
the reduced-penetrance categories for their sex. Two sub-
jects reported current use of oral contraceptives. Exclu-
sion of subjects who use these medications did not alter
the results (data not shown). The genetic marker for the
LpL gene was diallelic (presence of any mutant allele vs.
normal alleles). The allele frequency for the rare (mu-
tant) allele was set at 103, on the basis of the estimated
frequency of homozygous LpL deficiency of ∼106
(Brunzell 1995).
Linkage analysis of LDL particle size (age and sex
adjusted) as a continuous variable also was performed.
LDL particle size also was adjusted for the potential
effects of the LDL-R gene (Nishina et al. 1992; Rotter
et al. 1996) in family 2, by use of linear regression.
Recent simulations from the Genetic Analysis Work-
shops have indicated the importance of appropriate ad-
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3 W86R 4 AAGCTTGTGTCATCATCTTC
ATAAGTCTCCTTCTCCCAGT
HpaII digest
4 H136R 4 TTTTGGCAGAACTGTAAGCA
GACAGTCTTTTCACCTCTTA
SSCP
5 G188E 1/5 TGTTCCTGCTTTTTTCCCTTT
ATTAAGCGAAGATTTATTAT
AvaII digest
5 P207L 2/3 CATGCGAATGTCATACGAATGG
TCCTGGCTGAAAAGTACCTCCACTC
DdeI digest











Sex (male/female) 20/26 36/38 )
Age (years) 4021 3318 1.10
Total cholesterol 20348.8 19555.8 1.50
HDL cholesterol 36.911.1 44.711.2 !.02
LDL cholesterol 117.248.2 123.452.4 1.20
Total triglycerideb 264.2323 139.389.7 !.01
Apo-B 104.444.9 86.922.0 1.20
LDL particle size (A˚) 259.68.1 267.97.0 !.005
NOTE.—Values are presented as mean  standard deviation. All
lipid and lipoprotein data are age and sex adjusted. Lipid and lipo-
protein concentrations in mg/dl.
a Significance level estimated by robust standard errors and clus-
tering analysis to account for potential nonindependence of familial
data (see Statistical Analysis section).
b Tg was transformed with use of the ln value for statistical tests.
justment for covariates in mapping complex traits (God-
dard et al. 1995; Wijsman and Amos 1997). Given the
known relationship among LDL particle size, Tg, and
HDL-C, linkage analysis was performed on LDL particle
size also, after adjustment for Tg and HDL-C, by use
of genotype-specific linear multivariate regression coef-
ficients for ln, Tg, and HDL-C, in all families, simul-
taneously. This method of adjustment preserves the re-
lationship of LDL particle size with Tg and HDL-C
between heterozygous and normal genotypes and re-
moves variance in LDL particle size related to Tg and
HDL-C within genotypes.
Parameter estimates of the genetic model for LDL par-
ticle size were derived from a segregation analysis of
LDL particle size (age and sex adjusted) as a continuous
variable, reported elsewhere (Austin et al. 1993a), in the
same primarily Mormon families as previously men-
tioned. Although no specific single-gene model could be
excluded, the model chosen for the current linkage anal-
ysis was based on maximum-likelihood estimation. Al-
lele frequencies were .18 and .82, with a dominant mode
of inheritance for the rare allele, and genotypic means
for LDL particle size of 258.7 A˚ and 268.5 A˚, respec-
tively, with a common variance of 6.8 A˚ for both gen-
otypes. Genetic marker parameters were set to the same
values as in the linkage analysis of LDL subclass phe-
notype B, as described previously. These parameters
were used for all of the linkage analyses of LDL particle
size as a continuous variable.
Linkage analyses were performed by the MLINK sub-
routine of the LINKAGE computer program, version 5.1
(Lathrop et al. 1984). Because this study specifically in-
volved a linkage analysis of small LDL particles with a
candidate gene (the LpL gene), LOD scores at recom-
bination fraction (v) of zero were of primary interest,
although model misspecification might lead to a maxi-
mum LOD score (Zmax) at (Clerget-Darpoux et al.v 1 0
1986). We assessed heterogeneity of linkage between
families using the admixture test (Smith 1963), bymeans
of HOMOG, version 3.35 (Ott 1986).
Results
Five extended kindreds were identified, through pro-
bands referred for LpL deficiency, in which primary de-
fects in the LpL gene causing defective LpL lipolytic
activity were identified. Five different mutations in four
exons of the LpL gene were identified among these five
families (table 1). Mutations in probands of families 1
(G188E/2kb IN, exon 6), 2 (P207L), and 4 (W86R/
H136R) were reported elsewhere (Brunzell 1995).
Newly identified families with LpL mutations were fam-
ilies 3 (P207L) and 5 (G188E).
Of the 120 subjects, 46 were heterozygous for struc-
tural mutations in the LpL gene (table 2). Compared
with homozygous normal subjects, heterozygous sub-
jects had significantly higher Tg ( mg/dl vs.264.2 323
mg/dl, ) and lower HDL-C123.4 52.4 P ! .01
( mg/dl vs. mg/dl, ).36.9 11.1 44.7 11.2 P ! .02
There was a trend toward higher levels of apo-B among
heterozygous subjects, but the differences were not sig-
nificant statistically. LDL particle size was significantly
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Table 3




LOD SCORE AT v 
.0 .1 .2 .3 .4 .5
1 ( )n  20 .30 .20 .13 .07 .03 .0
2 ( )n  32 1.12 1.00 .78 .48 .18 .0
3 ( )n  27 .42 .33 .21 .10 .02 .0
4 ( )n  8 .06 .03 .02 .01 .0 .0
5 ( )n  33 .24 .19 .14 .10 .05 .0
Total 1.65 1.37 1.00 .56 .18 .0
NOTE.—Results were determined on the basis of five extended kin-
dreds with LpL mutations.
Figure 2 Prevalence of LDL subclass phenotypes. Light bars
indicate subjects homozygous for normal LpL alleles. Dark bars in-
dicate subjects heterozygous for mutations in the LpL gene.
smaller among LpL heterozygous subjects compared
with normal subjects ( A˚ vs. A˚,259.6 8.1 267.9 7.0
). Among heterozygous subjects, the prevalenceP ! .005
of LDL subclass phenotype B was 40%, versus 8%
among homozygous normal subjects (fig. 2).
Within LpL-heterozygous subjects, there was a strong
inverse relationship between LDL particle size and Tg
levels (ln transformed, , ), and therer  0.66 P ! .005
was a positive relationship between LDL particle size
and HDL-C levels ( , ). A similar rela-r  0.57 P ! .01
tionship was observed within homozygous normal sub-
jects, with a significant inverse relationship betweenLDL
particle size and ln-transformed Tg levels ( ,r  0.73
), and a significant positive relationship betweenP ! .001
LDL particle size and HDL-C levels ( , ).r  0.64 P ! .01
In multivariate analysis, both Tg and HDL-C levels were
independent predictors of LDL particle size. Together,
Tg and HDL-C accounted for 47% of the variance in
LDL particle size, within heterozygous subjects, and for
58% of the variance within homozygous normal
subjects.
Linkage analysis of LDL subclass phenotype B as a
qualitative trait gave modest positive LOD scores but
no statistically significant evidence of linkage (table 3;
at for all families). Among individualZ  1.65 v  0,max
families, family 2 had , whereas three fam-Z  1.12max
ilies (families 1, 3, and 4) had only modest positive LOD
scores. Family 5 had a small negative LOD score for
linkage of LDL subclass phenotype B to the LpL gene,
at .v  0
Without adjustment of LDL particle size for the var-
iance that results from Tg and HDL-C, there was sug-
gestive evidence for linkage of LDL particle size as a
quantitative trait to the LpL gene, with atZ  2.95max
. The LOD score at was 1.54 (table 4).v  0.11 v  0
This may indicate a bias in the estimation of v, as a
result of model misspecification (Clerget-Darpoux et al.
1986). Four families had positive LOD scores, with a
range of 0.26–1.50 at , whereas family 5 hadv  0
. When LDL particle size was adjusted forLOD  1.80
Tg and HDL-C, irrespective of the subject’s LpL geno-
type, there was no evidence for linkage of this trait to
the LpL gene. The overall LOD score was 1.18 at
(table 5).v  0
Linkage analysis of LDL particle size, by use of the
within-genotype adjustment for Tg and HDL-C, indi-
cated strong evidence for linkage to the LpL gene (table
6). For all families combined, at andZ  6.24 v  0,max
the LOD score maximized at in all families. Twov  0,
individual families had (family 2,LOD 1 2 LOD 
family 3, ). Two other families2.96; LOD  2.18
showed modest positive LOD scores (families 1 and 5),
and family 4 provided little additional information. The
x2 test of heterogeneity gave no evidence of linkage het-
erogeneity among these families ( ). Further-2x  0.0
more, LOD scores maximized at (fig. 3), suggest-v  0
ing that the LpL gene itself, and not another gene in this
region of chromosome 8p22, affects LDL particle size.
Thus, these families provide statistically significant evi-
dence of cosegregation of LDL particle size with the LpL
gene.
Discussion
In the present study, we present strong evidence that
mutations in the LpL gene affect LDL particle particle
size. Linkage analysis of LDL particle size (after adjust-
ment for within-genotype variance resulting fromTg and
HDL-C) to the LpL gene produced highly significant
evidence of linkage ( at ). The strategyLOD  6.24 v  0
used in the analysis of this complex trait was to select
families in which structural mutations in the LpL gene
were known to be segregating, thereby obtaining max-
imally informative marker genotypes in the linkage anal-
ysis. In addition, the trait was refined bywithin-genotype
quantitative adjustment for covariates (Tg and HDL-C)
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LOD SCORE AT v 
.0 .1 .2 .3 .4 .5
1 ( )n  20 .81 .62 .45 .29 .13 .0
2 ( )n  32 .77 1.67 1.54 1.10 .50 .0
3 ( )n  27 1.50 1.32 1.03 .67 .28 .0
4 ( )n  8 .26 .17 .09 .04 .01 .0
5 ( )n  33 1.80 .84 .43 .20 .06 .0
Total 1.54 2.94 2.69 1.90 .86 .0
NOTE.—LOD score values reflect LDL particle size as a quantitative
trait, adjusted for age and sex only, on the basis of five extended
kindreds with LpL mutations.
Table 5




LOD SCORE AT v 
.0 .1 .2 .3 .4 .5
1 ( )n  20 .65 .36 .19 .08 .02 .0
2 ( )n  32 .02 .01 .01 .0 .0 .0
3 ( )n  27 .43 .21 .11 .06 .02 .0
4 ( )n  8 .06 .03 .01 .0 .0 .0
5 ( )n  33 .15 .04 .08 .06 .03 .0
Total 1.18 .51 .21 .08 .01 .0
NOTE.—LOD score values are adjusted for age, sex, and variance
resulting from Tg and HDL-C, irrespective of genotype, in five ex-
tended kindreds with LpL mutations.
that are associated with LDL particle size. The present
study is the first to show evidence of genetic linkage of
LDL particle size to a QTL with structural mutations
that are known to influence protein function.
Although other studies have investigated linkage of
LDL subclass phenotypes or LDL particle size to other
candidate genes, the results have not been definitive.
Nishina et al. (1992) reported evidence for linkage of
LDL subclass phenotype B to the LDL-R gene, but they
were unable to identify any mutations in the coding re-
gion of LDL-R gene in those families (Nishina et al.
1992; Naggert et al. 1997). One sib-pair analysis sug-
gested that four genes influence LDL particle size, in-
cluding the LDL-R gene (Rotter et al. 1996); however,
in another sib-pair analysis, this was not confirmed (Aus-
tin et al. 1998). The present study does not exclude the
possibility that the LDL-R gene influences LDL particle
size. In fact, in one family in which the LDL-R structural
mutation W66G was segregating (family 2), there was
a modest 3-A˚ increase in LDL particle size among car-
riers with that LDL-R mutation, accounting for 4% of
the variation in LDL particle size.
In another sib-pair analysis of polymorphic sites in
and near the LpL gene, there was no evidence of linkage
of the LpL gene to LDL particle size in families with
coronary disease (Rotter et al. 1996). The apparent dis-
crepancy with the present study may simply reflect the
expected infrequency of mutations in the LpL gene in a
sample not ascertained on the basis of these mutations.
A second possible explanation is that sib-pair methods
have low power relative to classic LOD score methods,
if the genetic model is specified appropriately (Demenais
and Amos 1989); thus, failure of the sib-pair analysis to
detect linkage may represent a type-II error.
There are several important methodological aspects,
which contributed to the ability to detect linkage in this
study, that should be emphasized. The identification of
families through probands with known mutations that
alter protein structure and function provided a unique
opportunity to assess the impact of the LpL gene on
LDL particle size, because there is a direct relationship
between the alleles of interest and altered LpL lipolytic
function. This strategy led to a more genetically ho-
mogeneous sample, with respect to the LpL function.
Use of such a homogeneous sample increases power in
mapping a QTL for a complex trait.
In addition, these results clearly demonstrated the
value of using quantitative traits, rather than qualitative
traits, for linkage analysis. This recently was identified
as a key factor in improving power in linkage analyses
of simulated data (Graham et al. 1997; Wijsman and
Amos 1997). In the present study, linkage analysis of
the quantitative trait, LDL particle size, achieved a 78%
increase in the Zmax compared with the linkage analysis
of the qualitative trait, LDL subclass phenotype (table
3 and table 4). This illustrates the inherent loss of in-
formation that results from dichotomizing a quantitative
trait (Graham et al. 1997). There is also loss of power
resulting from the inability to adjust the dichotomous
trait for the within-genotype effects of Tg and HDL-C.
Appropriate adjustment for covariates that influence
LDL particle size was another important factor in iden-
tifying significant evidence for genetic linkage. When the
within-genotype variance of LDL particle size related to
Tg and HDL-C was taken into account, Zmax was more
than twice that obtained without adjustment for these
physiologic covariates (table 4 and table 6) and was
more than sixfold higher when compared with the LOD
score of LDL particle size adjusted for Tg and HDL-C,
irrespective of genotype (table 5 and table 6). Thus, the
adjustment of LDL particle size for the genotypic-specific
effects of Tg and HDL-C illustrates the importance of
appropriate covariate adjustment in detecting evidence
for linkage of LDL particle size to the LpL gene. Similar
results obtained on the basis of simulated data have been
reported (Goddard et al. 1995; Wijsman and Amos
1997). The present study shows the striking impact of
appropriate adjustment of physiologic covariates on
mapping QTLs in a natural setting.
Small LDL particles, elevated levels of Tg, and low
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Table 6




LOD SCORE AT v 
.0 .1 .2 .3 .4 .5
1 ( )n  20 .67 .48 .29 .14 .04 .0
2 ( )n  32 2.96 2.92 2.34 1.54 .67 .0
3 ( )n  27 2.18 1.73 1.26 .76 .29 .0
4 ( )n  8 .03 .02 .01 .0 .0 .0
5 ( )n  33 .41 .33 .16 .04 .01 .0
Total 6.24 5.48 4.00 2.49 1.01 .0
NOTE.—LOD score values are adjusted for age, sex, and within-
genotype variance resulting from Tg and HDL-C, in five extended
kindreds with LpL mutations.
Figure 3 LOD scores at for linkage of LDL particlev  0–0.5,
size to the LpL gene, after adjustment for within-genotype effects of
Tg and HDL-C.
levels of HDL-C are components of an atherogenic li-
poprotein phenotype (ALP; Austin et al. 1990b), and it
is interesting to note that these relationships were ob-
served both between and within normal and LpL-het-
erozygous subjects. The strategy of using within-geno-
type adjustment of LDL particle size for Tg and HDL-C
removed the variance in LDL particle size related to ALP
within genotypes and preserved the relationship of LDL
particle size to ALP between genotypes. Thus, in families
with structural mutations in the LpL gene, LpL hetero-
zygosity accounts for only a portion of ALP. A residual
relationship among LDL particle size, Tg, and HDL-C
exists, both in normal and LpL-heterozygous subjects,
suggesting that there are additional factors controlling
this phenotype.
The present study provides strong evidence that LpL
plays a primary role in lipid metabolism and the for-
mation of small LDL particles. Low LpL activity has
been shown to be associated with an increase in Tg (Nik-
kila et al. 1978), as a result of delayed clearance of Tg-
rich LDL precursors (Taylor et al. 1980; Magill et al.
1982). This decrease in LpL activity leads to an increase
in LDL particle density (Hokanson et al. 1997b). In ad-
dition, low LpL activity is associated with a decrease in
levels of HDL-C (Nikkila et al. 1978) and apo-A-I (Ma-
gill et al. 1982) plasma levels. The present study shows
that a genetic defect in the LpL gene, which leads to
reduced LPL activity, influences lipid metabolism and
leads to smaller LDL particles.
The structural mutations examined in this study are
too rare to account fully for the common trait of small
LDL particle size in the general population. However,
two variants in the LpL gene, D9N and N291S, cause
modest reductions of LpL lipolytic activity (Zhang et al.
1996) and are relatively common (Mailly et al. 1995;
Assmann et al. 1996; Mailly et al. 1996). Given the
results of the present study, it will be important to ex-
amine the role of these and other variations in the LpL
gene as causes of small LDL particles. In addition, struc-
tural variants in the LpL gene also are associated with
coronary disease (Hokanson 1997; Nordestgaard et al.
1997). The results reported here suggest that the increase
in small LDL particles, and the associated lipid abnor-
malities, are a potential mechanism by which hetero-
zygosity for LpL mutations could lead to an increase in
coronary disease risk.
In conclusion, LOD score–linkage analysis provides
highly statistically significant evidence for genetic link-
age of LDL particle size to the LpL locus, in families
with structural mutations in the LpL gene. The present
study dramatically illustrates the importance of the use
of a quantitative trait (i.e., LDL particle size) in linkage
analyses and the value of covariate adjustments (i.e.,
LDL particle size adjusted for within-genotype affects of
Tg and HDL-C), when mapping QTLs. In addition, this
study suggests that a potential mechanism by which sub-
jects heterozygous for structural mutations in the LpL
gene are at increased risk for coronary disease is through
the formation of small LDL particles.
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